Creating New Targeted Antibacterial Products to Help Tackle Antimicrobial Resistance

We speak to Matthew Dunne, Director for Drug Discovery at Micreos Pharmaceuticals, about the importance of creating new targeted antibacterial products.

Related Keywords

Zurich ,Züsz ,Switzerland ,Hamburg ,Germany ,Ireland ,Swiss ,Jarun Ontakrai Shutterstock ,Alyssa Hill ,Matthew Dunne ,Martin Loessner ,Samuel Kilcher ,Emily Henderson ,Discoverymicreos Pharamceuticals ,Schmelcherm Linker ,Swiss Federal Institute Of Technology Zurich ,Division Of Antimicrobial Vectors ,University College Cork ,World Health Organization ,University Of Birmingham ,European Molecular Biology Laboratory ,Swiss Institute Of Technology ,Drug Discovery At Micreos Pharmaceuticals ,Micreos Pharmaceuticals ,Division Of Antimicrobial Vector Innovation ,Leadersmatthew Dunnedirector ,Drug Discoverymicreos ,World Antimicrobial Awareness Week ,Drug Discovery ,Antimicrobial Vector ,Swiss Federal Institute ,Technology Zurich ,Antimicrobial Vectors ,Discovery Industry Focus ,Preventing Antimicrobial Resistance ,World Health ,Structural Biology ,Senior Scientist ,Swiss Institute ,Pharmaceutical Chemistry ,Red Sox ,Reconstituted Human Epidermis ,Murine Model ,Antimicrob Agents ,Antimicrobial Resistance ,Agriculture ,Ntibiotic ,Bacteria ,Iochemistry ,Fell ,Cell Wall ,Hronic ,Climate Change ,Education ,Efficacy ,Gene ,Genes ,Enetic ,Genetic Engineering ,Medicine ,Pharmaceuticals ,Reclinical ,Preclinical Testing ,Protein ,Research ,Skin ,Staphylococcus Aureus ,Herapeutics ,